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Abstract
The aim of this research was to investigate the antiproliferative and anticholinesterase activities of 11 extracts from 5
Annonaceae species in vitro. Antiproliferative activity was assessed using 10 human cancer cell lines. Thin-layer
chromatography and a microplate assay were used to screen the extracts for acetylcholinesterase (AchE) inhibitors using
Ellman’s reagent. The chemical compositions of the active extracts were investigated using high performance liquid
chromatography. Eleven extracts obtained from five Annonaceae plant species were active and were particularly effective
against the UA251, NCI-470 lung, HT-29, NCI/ADR, and K-562 cell lines with growth inhibition (GI50) values of 0.04-0.06,
0.02-0.50, 0.01-0.12, 0.10-0.27, and 0.02-0.04 mg/mL, respectively. In addition, the Annona crassiflora and A. coriacea seed
extracts were the most active among the tested extracts and the most effective against the tumor cell lines, with GI50 values
below 8.90 mg/mL. The A. cacans extract displayed the lowest activity. Based on the microplate assay, the percent AchE
inhibition of the extracts ranged from 12 to 52%, and the A. coriacea seed extract resulted in the greatest inhibition (52%).
Caffeic acid, sinapic acid, and rutin were present at higher concentrations in the A. crassiflora seed samples. The A. coriacea
seeds contained ferulic and sinapic acid. Overall, the results indicated that A. crassiflora and A. coriacea extracts have
antiproliferative and anticholinesterase properties, which opens up new possibilities for alternative pharmacotherapy drugs.
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Introduction
Annonaceae is a large family of plants in the Cerrado
region of Brazil, comprising approximately 27 genera and
290 species and including a large variety of exotic fruits.
These plants are found in rural areas and are commonly
consumed in natura by native people or used in the
preparation of juice or ice cream. The fruits are known as
‘araticum do cerrado’ or ‘marolo’ (1). Many members of the
Annonaceae family are used in folk medicine for antipar-
asitic or antitumoral treatment of intestinal diseases. Some
species in the Annonaceae family have been intensely
studied for the isolation and characterization of their diverse
classes of compounds and pharmacological properties,
including anticancer and anticholinesterase activities (2-5).
Our preliminary studies of the pharmacological proper-
ties of Annona species indicated that the methanolic
extract and fractions of the leaves from A. dioica exert
anti-inflammatory, hypoglycemic, antiproliferative, and
antioxidant effects (6). The essential oil from the leaves
of A. sylvatica exhibited anti-inflammatory and anticancer
activities (7), and a methanolic extract and the ethyl
acetate fraction (EAF) showed anti-mycobacterial activity
(8). Furthermore, Annona species have potential as
insecticides because they inhibit the development and
reproduction of Spodoptera frugiperda (9).
The prevalence and use of medicinal plants among
the Annonaceae family and the biological potential and
significance of finding new potentially active agents have
drawn us to study this family (especially the Annona and
Duguetia species). The popular uses, parts of the plant
used, and extraction yields of the plants that were
Correspondence: A.S.N. Formagio: aneliseformagio@ufgd.edu.br.
Received May 17, 2014. Accepted October 13, 2014. First published online February 13, 2015.
Brazilian Journal of Medical and Biological Research (2015) 48(4): 308-315, http://dx.doi.org/10.1590/1414-431X20144127
ISSN 1414-431X
Braz J Med Biol Res 48(4) 2015 www.bjournal.com.br
selected for this study are reported in Table 1. However,
more evidence is required to determine the antitumor
effects and acetylcholinesterase (AchE) inhibitory proper-
ties of these species, which have not been investigated to
date. The present study investigated the antiproliferative
and anticholinesterase activities of 11 extracts from 5
Brazilian Annonaceae plants in vitro.
Material and Methods
Plant material
Vegetative samples of the 5 species were collected in
Dourados (S 226 089 250, W 556 089 170), MS, Brazil.
Botanical identification was conducted by Dr. Zefa
Valdivina Pereira, Faculdade de Cieˆncias Biolo´gicas e
Ambientais, Universidade Federal da Grande Dourados
(FCBA, UFGD), Dourados, MS, Brazil. The specimens
were deposited in the Herbarium of the FCBA, UFGD
(Table 1) (10-16). In addition to the data from the
literature, we investigated the main species from the
Annonaceae family that were present in the Dourados
region and used by the population.
Preparation of crude extracts
Annona crassiflora (L: leaves and S: seeds), A.
coriacea (L, C: floral capitulum, and S), A. sylvatica (L
and S), A. cacans (L), and Duguetia furfuracea (L, C and
S) were air-dried and exhaustively extracted by macera-
tion using methanol at room temperature. The solvent
was evaporated under vacuum at 406C and lyophilized to
obtain the methanol extract of each sample studied.
In vitro antiproliferative activity assay
The human tumor cell lines UACC-62 (melanoma),
MCF-7 (breast), NCI/ADR/RES (ovarian tumor expressing
the phenotype of multiple drug resistance), 786-0 (renal),
NCI-H460 (lung, non-small cells), OVCAR-3 (ovarian), HT-
29 (colon), K562 (leukemia), UA251 (glioma), and VERO
(green monkey kidney cells) were kindly provided by the
Frederick National Laboratory for Cancer Research,
Frederick, MD, USA. Stock cultures were grown in 5 mL
of RPMI 1640 (Gibco-BRL, Life Technologies, USA)
supplemented with 5% fetal bovine serum. Penicillin and
streptomycin (1 mL/L, at a ratio of 1000 mg/mL:1000 IU/
mL) were added to the experimental cultures. Cells in
96-well plates (100 mL cells/well) were exposed to each
extract in dimethyl sulfoxide (DMSO; 0.25, 2.5, 25, and
250 mg/mL) and 5% CO2 at 376C for 48 h. The final
concentration of DMSO did not affect cell viability.
Next, the cells were fixed with a trichloroacetic acid
solution (50%, v/v), and cell proliferation was determined
via spectrophotometric quantification (540 nm, Molecular
Devices Versa Max microplate reader, USA) of the
cellular protein content using a sulforhodamine B assay
(17). Doxorubicin (0.025-25 mg/mL) was used as a
positive control, and averages were calculated from
absorbance. Cell proliferation was determined using the
equation 1006[(T–To)/C0–To], where T is the absor-
bance of the treated cell, To is the absorbance of the
control cells at the beginning of the incubation, and C0 is
the absorbance of the control. These values were
determined from nonlinear regression analysis using the
Origin software, version 7.5 (USA). The results were
subtracted from 100% to obtain the percent growth
inhibition. The samples were considered active when
growth inhibition was greater than 50% (GI50). A cytostatic
effect (TGI) was observed when T>To, and a cytocidal
effect (LC50) was observed when T,To. The experiments
were performed in triplicate.
Measurement of AchE activity
The solutions used were as follows: 50 mM Tris/HCl,
Table 1. Selected plant species from Annonaceae evaluated for antiproliferative and acetylcholinesterase inhibitory activities.
Plant species
(Voucher)
Vernacular name Ethnomedical use Part of
plant
tested1
Extraction
yield (% w/w)
Annona crassiflora
Mart. (DDMS 4599)
‘‘araticum do
cerrado’’ or
‘‘marola’’
The oil from the seeds is used against snake bites and
in folk medicine, the leaf and seed infusion is used
against diarrhea, antitumor, and for the treatment of
Chagas’ disease (1,10)
L, S L (42%)
S (16.8%)
A. coriacea Mart.
(DDMS 186)
‘‘marola’’, ‘‘araticum’’
or ‘‘araticum-liso’’
Seeds and leaves are used against chronic diarrhea
(11), antimalarial (12), rheumatism (13), anti-helmintic
(14), and leishmaniasis (15)
L, S, C L (52.6%)
S (13.5%)
C (5.1%)
A. sylvatica St.-Hil
(DDMS 4600)
‘‘araticum da mata’’ Leaves are used for ulcers caused by syphilis, muscle
spasms, angina, diarrhea, or as a febrifuge (16)
L, S L (36.4%)
S (8.0%)
Cacans Mart.
(DDMS 4885)
‘‘araticum caga˜o’’ Not reported L L (40.8%)
Duguetia furfuracea
A.St.-Hil (DDMS 166)
‘‘araticum seco’’ or
‘‘araticum miu´do’’
Leaves are used as a parasiticide and against
rheumatism (12)
L, S, C L (30.0%)
S (8.5%)
C (6.6%)
L: leaves; S: seeds; C: floral capitulum. 1Methanol was used as the solvent.
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pH 8; 50 mM Tris/HCl, pH 8, containing 0.1% BSA;
50 mM Tris/HCl, pH 8, containing 0.1 M NaCl and
0.02 M MgCl2.6H2O; 3 mM 5,59-dithiobis-(-2-nitrobenzoic
acid) (DTNB or Ellman’s reagent), 15 mM acetylcholine
iodide (ATCI), 1 mM Ellman’s reagent, and 1 mM ACTI.
Lyophilized enzyme AchE was dissolved in the Tris/HCl
buffer solution, pH 8, to obtain a 1000 U/mL stock
solution. This solution was allowed to rest for 20 min
and then stirred for 10-15 min to obtain a homogeneous
solution. For subsequent dilutions, the Tris/HCl buffer
solution at pH 8 and containing 0.1% BSA was used.
Microplate assay
The enzyme hydrolyzed the acetylcholine substrate
and generated thiocholine, which reacted with the
Ellman’s reagent to produce 2-nitrobenzoate-5-mercap-
tothiocoline and yellow-colored 5-thio-2-nitrobenzoate
anion, which can be detected at 405 nm (18). Twenty-
five microliters of 15 mM ATCI, 125 mL of 3 mM Ellman’s
reagent, and 50 mL of Tris/HCl, pH 8, containing 0.1%
BSA were added to the 96-well plates. Next, 25 mL of the
extract to be analyzed was dissolved in methanol and
diluted 10 times with Tris/HCl, pH 8. The absorbance was
read 5 times every 13 s. Next, 25 mL of the enzyme
(0.22 U/mL) was added, and the absorbance was
measured 8 times every 13 s. The speed of the reaction
was calculated. Possible increases in the absorbance rate
due to spontaneous hydrolysis were corrected by sub-
tracting the speed of the reaction before the enzyme was
added from the speed of the reaction after the enzyme
was added. Next, the inhibition percentage was calculated
by comparing the speeds of the sample reactions to a
blank (10% methanol, Tris/HCl, pH 8).
Thin-layer chromatography (TLC) assay
Aliquots (1.5-2.5 mL) of each extract were spotted on
silica gel plates (60 F254, 0.2 mm, Merck, USA) and
developed in chloroform/methanol (8:2 v/v) solvent. The
plate was then sprayed with 1 mM DTNB and 1 mM ACTI
solution, dried for 3-5 min, and then 3 U/mL of the enzyme
solution was sprayed on the plate. Within 10 min, a yellow
color appeared, and white spots were observed where the
inhibiting effect of the enzyme was present. The coloration
disappeared between 20 and 30 min.
LC analysis of the standards and samples
The extracts and standards were analyzed in an
analytical LC (Varian 210) system with a ternary solvent
delivery system equipped with an autosampler and a
photodiode array detector (PDA) monitored at l=200-
800 nm. The LC column was a C-18 column (4.6 mm 6
25 cm; particle size, 5 mm; Luna, Phenomenex, USA) with
a pre-column (3 mm 6 2.5 cm) containing the same
packing material. The injection volume was 20 mL and the
flow rate 1.0 mL/min at 226C. The column was eluted with
sodium acetate (2 mM; Solvent A) and acetonitrile
(Solvent B). The following solvent gradient program was
used: 10% Solvent B in 10 min, 15% in 5 min, 100% in
15 min.
Linearity. The content estimation of the standards
[caffeic acid (98%), p-coumaric acid (98%), ferulic acid
(99%), sinapic acid (98%), luteolin (98%), quercetin
(99%), rutin (98%), kaempferol (98%), and apigenin
(95%) purchased from Sigma Aldrich, USA] in the
samples (methanolic extract of A. crassiflora and A.
coriacea seeds) was performed using external calibration.
Next, 20 mL aliquots of the dilutions were analyzed via LC.
Each determination was conducted 5 times. For the
standard, the corresponding chromatogram was obtained
and a graph was constructed from the mean of the
chromatogram areas plotted against the standards at a
concentration of 1-50 mg/mL. A linear least-squares
regression of the peak areas was performed as a
function of the concentrations to determine the
correlation coefficients. Equation parameters (slope and
intercept) of the standard curve were used to obtain the
concentration values for the samples.
Results
Plant material – methanolic extract
Extracts from the lyophilized leaves (L) and seeds (S)
of A. crassiflora, A. coriacea, A. sylvatica, A. cacans, and
Duguetia furfuracea showed high yields (L: efficiency
values of 30.0-52.6%; S: efficiency values of 10.2-16.8%;
Table 1) when methanol was used as the extractor liquid.
The yield was calculated using the total dry mass of the
plant extract (w/w).
Antiproliferative activity assay
The antiproliferative properties of the 11 extracts of
Annonaceae were assessed in 10 human cancer cell
lines, with the chemotherapeutic drug doxorubicin as
positive control. The response parameter (GI50) was
calculated for each tested extract cell line, and the
results are summarized in Table 2. The GI50 values
(growth inhibitory activity) refer to the drug concentra-
tions that resulted in a 50% reduction in the cellular
growth relative to the untreated control cells. The TGI
(cytostatic activity) and LC50 (cytotoxic activity) value
parameters refer to the drug concentrations for total
growth inhibition and for killing 50% of the cells,
respectively (as shown in Table 3).
All evaluated seed extracts exhibited broad antiprolif-
erative effects (Table 2). The A. coriacea extract showed
GI50 values ranging from 0.02-3.83 mg/mL against all of
the tested human tumor cell lines, showing effective
growth inhibition against specific cell lines, including
UA251 (GI50=0.04 mg/mL), HT-29 (GI50=0.03 mg/mL),
NC I -H460 (G I 5 0=0 . 0 2 m g /mL ) , a n d K - 5 6 2
(GI50=0.02 mg/mL). In addition, A. crassiflora possessed
potent antitumor activity against all of the 10 human tumor
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cell lines assayed with a GI50 of less than 10 mg/mL,
which showed GI50 values within the 0.01 to 8.90 mg/mL
range (Table 2). The highest growth inhibitory activities
occurred toward UA251 (GI50=0.06 mg/mL), VERO
(GI50=0.05 mg/mL), NCI-H460 (GI50=0.04 mg/mL), and
HT-29 (GI50=0.01 mg/mL) cells (Table 2). A. sylvatica
extract showed inhibitory activity against the NCI/ADR/
RES, 786-0 (GI50=0.06 mg/mL), NCI-H460, HT-29, and
K-562 (GI50=0.02 mg/mL) cell lines (Table 2). The D.
furfuracea extract presented the highest growth inhibitory
activity toward UA251 (GI50=0.04 mg/mL), NCI-H460
(GI50=0.09 mg/mL), and HT-29 (GI50=0.02 mg/mL) cell
lines (Table 2).
In addition, the A. coriacea extract showed potent
activity (mean TGI value=8.19 mg/mL) with very similar
effects on UA251 (TGI=4.59 mg/mL), UACC-62
(TGI=8.01 mg/mL), MCF-7 (TGI=9.00 mg/mL), NCI-
H460 (TGI=2.66 mg/mL), 786-0 (TGI=7.17 mg/mL), HT-
29 (TGI=5.92 mg/mL), OVCAR-3 (TGI=10.12 mg/mL),
K562 (TGI=4.69 mg/mL), and VERO (TGI=5.91 mg/mL)
cell lines (Table 3). Furthermore, A. coriacea exhibited
cytotoxic activity with LC50 levels of 13.64-34.67 mg/mL
against the 6 cell lines shown in Table 3. Another extract
that presented weak antiproliferative activity was the A.
crassiflora extract (mean TGI value=28.16 mg/mL), with
a selective effect on HT-29 (TGI=0.10 mg/mL) and NCI/
ADR/RES (TGI=6.56 mg/mL, LC50=24.29 mg/mL) cell
lines (Table 3).
For the extracts obtained from the floral capitulum, D.
furfuracea (GI50=0.07 mg/mL) and A. coriacea
(GI50=0.04 mg/mL) were particularly effective against
the K-562 cell line (Table 2). In addition, A. coriacea also
showed moderate act iv i ty against the HT-29
(GI50=0.12 mg/mL), NCI/ADR (GI50=0.27 mg/mL), and
NCI-460 (GI50=0.50 mg/mL) cell lines (Table 2).
Regarding the extracts obtained from the leaves, A.
coriacea and A. sylvatica demonstrated high activities
against speci f ic ce l l l ines toward NCI-H460
(GI50=0.02 mg/mL; GI50=0.06 mg/mL) and HT-29
(GI50=0.08 mg/mL; GI50=0.01 mg/mL), respectively
(Table 2). In addition, A. sylvatica demonstrated high
activity against UA251 (GI50=0.05 mg/mL), and A.
coriaceae demonstrated high activity against NCI/ADR/
RES and VERO (GI50=0.10 mg/mL) cell lines (Table 2).
Extracts from A. crassiflora, A. cacans, and D. furfuracea
did not show activity against the cell lines.
AchE activity assay
The results from the extracts tested for AchE inhibition
are presented in Table 4. The extracts were tested at
concentrations of 1.0-2.0 mg/mL. Some extracts were not
soluble in methanol, which limited the analysis in the
microplate. Based on the microplate assay, the percen-
tage of AchE inhibition by the extracts varied from 12 to
52%, with the seed extract of A. coriacea showing the
greatest inhibition (52%).
Table 2. In vitro antitumor activity (GI50 in mg/mL) of the methanolic extracts from the Annonaceae plants against the tumor cell lines.
Extract Cancer cell line
UA251 UACC-62 MCF-7 NCI-
H460
786-0 HT-29 NCI/ADR/
RES
OVCAR-3 K562 VERO
Doxorubicin 5.13 0.06 0.14 0.05 0.22 2.20 1.68 0.30 0.89 1.38
A. crassiflora
L 5.09 28.12 24.95 3.86 .100 2.49 11.61 44.83 26.02 14.14
S 0.06 3.78 3.54 0.04 5.33 0.01 0.25 8.90 3.25 0.05
A. coriacea
L .100 1.76 5.58 0.02 37.69 0.08 0.10 36.47 21.11 0.10
S 0.04 2.92 2.63 0.02 3.74 0.03 0.25 3.83 0.02 0.12
C 1.80 29.32 4.43 0.50 25.41 0.12 0.27 15.98 0.04 6.33
A. sylvatica
L 0.05 26.41 29.85 0.06 69.14 0.01 1.94 36.47 5.30 41.60
S 0.10 32.27 29.68 0.02 0.06 0.02 0.06 36.68 0.02 1.87
A. cacans
L 49.47 32.27 57.97 78.63 63.97 50.82 59.90 49.18 33.55 51.28
D. furfuracea
L 34.36 27.22 60.62 48.16 79.81 78.63 37.80 77.92 58.49 56.09
S 0.04 54.60 62.28 0.09 – 0.02 1.71 – 2.34 2.27
C 32.27 34.04 42.23 44.69 86.52 23.79 49.03 54.77 0.07 .100
L: leaves; S: seeds; C: floral capitulum; UA251 (glioma); UACC-62 (melanoma); MCF-7 (breast); NCI-H460 (lung); 786-0 (renal); HT-29
(colon); NCI-ADR/RES (ovarian expressing the phenotype of multiple drug resistance); OVCAR-3 (ovarian); K562 (leukemia); VERO
(monkey kidney normal cells); –: not presented.
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LC analysis
The most active extracts of the A. coriacea and A.
crassiflora seeds were investigated using chemical char-
acterization. Identification of the compounds using a PDA
detector over a spectral range of 200-800 nm did not reveal
any interference in the retention time of the samples in LC
when using the developed elution method. Standards were
easily identified and quantified based on their absorption
spectra in the UV region and their retention time. The
standards that were found in the extracts were unambigu-
ously identified by performing co-injection experiments, in
which aliquots of the extracts and standards were mixed
and diluted to a known volume and analyzed using LC.
The calibration curves were determined by linear
regression using LC. The linearity of the standards was
assessed using 5 concentration ranges. The average
standard errors for the peak areas of the replicated
injections (n=5) were less than 1%, showing good
repeatability of the calibration curve. The respective
coefficients of determination (r2) were 0.9994 for caffeic
acid and p-coumaric acid, 0.992 for ferulic acid and
sinapic acid, and 0.9996 for luteolin, kaempferol, querce-
tin, rutin, and apigenin. Caffeic acid (retention time
(rt)=1.73 min; 302 mg/mL), sinapic acid (rt=3.75 min;
248 mg/mL), and rutin (rt=4.98 min; 493 mg/mL) were
present in higher concentrations in the sample of A.
crassiflora seeds. The p-coumaric acid (rt=2.56 min;
106 mg/mL) and ferulic acid (rt=2.98 min; 176 mg/mL)
showed smaller concentrations. The A. coriacea seeds
contained ferulic acid (rt=2.99 min; 197 mg/mL) and
sinapic acid (rt=3.75 min; 256 mg/mL; Figure 1A and B).
Discussion
Extract yield is an important factor for evaluating the
extraction capacity of a solvent and the extraction
Table 3. Cytostatic (TGI, mg/mL) and cytocidal effects (LC50, mg/mL; data in parentheses) for methanolic extracts from the
Annonaceae.
UA251 UACC-
62
MCF-7 NCI-
H460
786-0 HT-29 NCI/
ADR/
RES
OVCAR-
3
K562 VERO TGI
mean
value
Doxorubicin 23.98
(–)
0.86
(–)
23.98
(–)
– 1.54
(–)
7.31
(21.49)
23.95
(–)
1.73
(–)
– 11.42
(–)
11.84
A. crassiflora
L 186.87
(–)
63.59
(.100)
63.78
(.100)
28.12
(.100)
– 9.11
(49.47)
66.31
(.100)
145.56
(–)
167.77
(–)
– 91.39
S 55.59
(–)
11.75
(45.23)
25.56
(78.63)
16.03
(–)
57.79
(.100)
0.10
(50.82)
6.56
(24.29)
37.69
(95.48)
– 42.35
(.100)
28.16
A. coriacea
L – 188.43
(–)
134.87
(–)
165.62
(–)
72.31
(.100)
– 145.90
(–)
133.65
(–)
– 47.16
(.100)
125.99
S 4.59
(17.22)
8.01
(21.75)
9.00
(–)
2.66
(13.64)
7.17
(14.18)
5.9
(72.53)
23.79
(–)
10.12
(34.67)
4.69
(–)
5.91
(18.62)
8.19
C 55.44
(.100)
80.29
(.100)
43.12
(.100)
– 56.60
(.100)
– – 77.23
(–)
44.83
(.100)
– 59.58
A. sylvatica
L 19.24
(–)
59.37
(.100)
– – – 0.36
(.100)
– 84.22
(.100)
– 91.03
(.100)
50.84
S 26.97
(90.48)
68.53
(.100)
145.86
(–)
4.88
(–)
65.92
(.100)
3.86
(–)
58.66
(–)
89.94
(.100)
74.06
(–)
48.31
(.100)
58.70
A. cacans
L 167.86
(–)
156.67
(–)
– – 189.56
(–)
– – – – 168.98
(–)
170.77
D. furfuracea
L 143.88
(–)
– 179.90
(–)
256.56
(–)
– – – – – 244.78
(–)
206.28
S 167.43
(–)
– – 289.56
(–)
– 11.20
(–)
287.98
(–)
– – – 189.04
C 78.16
(.100)
75.18
(.100)
– – 72.31
(.100)
– 156.54
(–)
57.28
(–)
– 87.89
L: leaves; S: seeds; C: capitulum floral; UA251 (glioma); UACC-62 (melanoma); MCF-7 (breast); NCI-H460 (lung); 786-0 (renal); HT-29
(colon); NCI/ADR/RES (ovarian tumor expressing the phenotype of multiple drug resistance); OVCAR-3 (ovarian); K562 (leukemia);
VERO (monkey kidney normal cells); –: not presented.
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method. The leaf extracts from all species performed well
when subjected to extraction with alcohol (methanol). The
low extraction yield of the extracts that were obtained from
the floral capitulum of A. coriacea and D. furfuracea
resulted from the solvent extractor (methanol). These
vegetal samples are preferentially extracted in methanol-
water, most likely by more polar substances.
When analyzing the bioassay results, an interesting
antiproliferative effect was observed for the majority of
methanolic extracts that were obtained from the 5
Annonaceae plants. The antiproliferative effect was
particularly effective against UA251, NCI-H460, HT-29,
NCI/ADR/RES, and K-562 cell lines. The extracts that
were obtained from A. cacans and D. furfuracea leaves
did not reveal antiproliferative activity.
Our previous studies have shown that the essential
oils of A. sylvatica leaves exhibited antiproliferative
activity, with GI50 values of between 36.04 and
45.37 mg/mL. However, at the highest concentrations,
cytostatic activity and cytotoxic effects were observed for
all of the cell lines (7).
In an earlier work, the in vitro antitumor activities of A.
crassiflora and D. furfuracea were reported. The cytotoxi-
city of the extracts that were tested against human colon
carcinoma, leukemia, brain, and melanoma tumor cell
lines at 50 mg/mL demonstrated substantial antiprolifera-
tive effects, with at least 85% inhibition of cell proliferation
in one or more of the cell lines (19). Coriadenin and
gigantetronenin were isolated from A. coriacea roots and
showed potent cytotoxicity against the VERO and KB cell
lines (20,21). This species is popularly known as marola,
and is known for its acetogenin (22-26) and alkaloid
Figure 1. Chromatogram of A. crassiflora (A) and A. coriacea (B)
seed extracts. 1: caffeic acid; 2: p-coumaric acid; 3: ferulic acid;
4: sinapic acid; 5: rutin.
Table 4. Acetylcholinesterase (AchE) inhibition by the methanolic extracts from some Annonaceae plants
in the microplate assay (% inhibition) and thin-layer chromatography (TLC).
Plant Concentration extracts
(mg/mL)
TLC Microplate assay
(% AchE inhibition)
A. crassiflora
L 2.0 + 22
S 1.5 + 45
A. coriacea
L 2.0 + 33
S 1.5 + 52
C 1.0 – 0
A. sylvatica
L 2.0 + 12
S 1.3 – 0
A. cacans
L 2.0 – 0
D. furfuracea
L 2.0 + 25
S 1.5 + 46
C 1.3 – 0
Donepezil 87
L: leaves; S: seeds; C: floral capitulum; +: inhibited; –: not inhibited.
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(3,27-31) content with cytotoxic potential.
Our studies revealed that the extracts obtained from
A. coriacea seeds displayed the most significant anti-
proliferative activities toward all of the tested cell lines.
Thus, these extracts are considered promising candidates
for future in vivo studies. In addition, the A. crassiflora
extract that was obtained from the seeds demonstrated a
potent antiproliferative effect. These extracts are rich in
phenolic acids, especially caffeic acid, sinapic acid, ferulic
acid and flavonoid, and exhibited significant anticancer
activities that could be attributed, at least in part, to their
phenolic acid content. Several studies have demonstrated
the anticancer and anticholinesterase potentials of these
compounds (32-34).
Using the criteria of the American National Cancer
Institute for considering a promising crude extract for
further purification, the IC50 value must be less than
30 mg/mL (35). The extracts selected in our study showed
significant activity (IC50#0.10 mg/mL) and were consid-
ered promising for further bioassay-guided fractionation.
In addition, the tests performed on these extracts were
only performed in TLC and showed negative results.
Although the TLC assay is a qualitative method, it can
reliably indicate whether the compounds have positive
activities. The use of this TLC method along with the
quantitative microplate assay provides useful information
for further sample purification. Extracts with inhibition
values of more than 50% are considered suitable
candidates for future research.
The presence of phenolic compounds and tannins in
the methanolic extracts may result in false positives owing
to the promotion of denaturation of the AchE enzyme.
Therefore, it must be remembered that the in vitro tests
can only assist in optimization and selection, and cannot
be used to replace in vivo tests. AchE occurs mainly in the
central and peripheral nervous systems and at the
parasympathetic and neuromuscular junctions. The A.
coriacea seed extract can be considered a promising
candidate for future research regarding the activity of
AchE in different brain structures (such as the cerebral
cortex, hippocampus, cerebellum, and striate cortex),
because earlier data were not found in the literature
regarding the activity of this plant enzyme.
Briefly, our results demonstrate that methanolic
extracts of Annonaceae can inhibit the proliferation of
cancer tumor cells, especially the methanolic extract of A.
crassiflora and A. coriacea seeds, which were the most
active among the tested extracts (resulting in GI50 values
of less than 8.90 mg/mL against all of the tumor cell lines).
However, the methanolic extracts of A. coriacea seeds
were the most effective for reducing tumor cell growth at
the observed GI50, TGI, and LC50 levels, and inhibited
AchE activity according to the TLC test and microplate
assay. Future in vivo studies should be conducted with
toxicity studies to determine whether this plant induces
changes in the functionality of the cholinergic system,
especially in brain structures.
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